 , Anthracycline Topoisomerase Inhibitor , Anthracyclines , Anthracyclines and Related Substances , Antibiotics, Antineoplastic , Antineoplastic Agents , Antineoplastic and Immunomodulating Agents , BCRP/ABCG2 Substrates , BSEP/ABCB11 Substrates , BSEP/ABCB11 Substrates with a Narrow Therapeutic Index , Carbohydrates , Cardiotoxic antineoplastic agents , Cytochrome P-450 CYP2B6 Inhibitors , Cytochrome P-450 CYP2B6 Inhibitors (strength unknown) , Cytochrome P-450 CYP2D6 Inhibitors , Cytochrome P-450 CYP2D6 Inhibitors (strength unknown) , Cytochrome P-450 CYP3A Inhibitors , Cytochrome P-450 CYP3A Substrates , Cytochrome P-450 CYP3A4 Inhibitors , Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) , Cytochrome P-450 CYP3A4 Substrates , Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index , Cytochrome P-450 Enzyme Inhibitors , Cytochrome P-450 Substrates , Cytotoxic Antibiotics and Related Substances , Drugs causing inadvertant photosensitivity , Enzyme Inhibitors , Glycosides , Immunosuppressive Agents , Myelosuppressive Agents , Naphthacenes , Narrow Therapeutic Index Drugs , P-glycoprotein inducers , P-glycoprotein inhibitors , P-glycoprotein substrates , P-glycoprotein substrates with a Narrow Therapeutic Index , Photosensitizing Agents , Topoisomerase II Inhibitors , Topoisomerase Inhibitors